Biologics have revolutionized – and are revolutionizing – the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days’ exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars – particularly in curative cancer treatment, where they are relatively recent therapeutic options. ‘Fast Facts: Biosimilars in Hematology and Oncology’ provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients.
Buy this ebook and get 1 more FREE!
Language English ● Format EPUB ● Pages 128 ● ISBN 9781912776221 ● File size 5.5 MB ● Publisher S. Karger AG ● City Basel ● Country CH ● Published 2020 ● Edition 1 ● Downloadable 24 months ● Currency EUR ● ID 7729225 ● Copy protection Adobe DRM
Requires a DRM capable ebook reader